Suchergebnisse - "Villafana, Tonya L"

PubPharm (14)

1

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa

enthalten in: bioRxiv.org | 2024

von Madhi, S. | Baillie, V. | Cutland, C. | +48

2

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern : Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

enthalten in: Vaccine | 2023

von Koen, A. | Izu, A. | Baillie, V. | +33

3

Efficacy of the AZD1222 (ChAdOx1 nCoV-19) COVID-19 Vaccine Against SARS-CoV-2 Variants of Concern

enthalten in: bioRxiv.org | 2022

von Koen, A. | Izu, A. | Baillie, V. | +33

4

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002) : a single-blind, randomised, controlled, phase 2/3 trial

enthalten in: Lancet (London, England) | 2021

von Ramasamy, M. | Minassian, A. | Ewer, K. | +162

ErratumIn: Lancet. 2021 Dec 19;396(10267):1978. - PMID 33341142

5

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

enthalten in: Nature medicine | 2021

von Feng, S. | Phillips, D. | White, T. | +96

6

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa : an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial

enthalten in: The lancet. HIV | 2021

von Madhi, S. | Koen, A. | Izu, A. | +36

ErratumIn: Lancet HIV. 2022 Dec;9(12):e822. - PMID 35597256

7

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2021

von Feng, S. | Phillips, D. | White, T. | +18

8

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

enthalten in: The New England journal of medicine | 2021

von Madhi, S. | Baillie, V. | Cutland, C. | +145

CommentIn: Ann Intern Med. 2021 May;174(5):JC50. - PMID 33939483

9

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7) : an exploratory analysis of a randomised controlled trial

enthalten in: Lancet (London, England) | 2021

von Emary, K. | Golubchik, T. | Aley, P. | +64

CommentIn: Lancet. 2021 Apr 10;397(10282):1326-1327. - PMID 33798497

10

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine : a pooled analysis of four randomised trials

enthalten in: Lancet (London, England) | 2021

von Voysey, M. | Costa Clemens, S. | Madhi, S. | +178

CommentIn: Lancet. 2021 Mar 6;397(10277):854-855. - PMID 33676614